Quipt Home Medical Corp T.QIPT

Alternate Symbol(s): QIPT

Healthcare

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.

TSX:QIPT - Post by User

Quipt Home Medical Corp

Bullboard Posts

Comment by adamwill1113on Aug 31, 2018 12:34pm

163 Views

Post# 28549290

RE:RE:3x the EBITDA Growth at 1/3 of the Price of VMD.TO & HTL.V…

I really hope I am wrong, but I think I am starting to see this scenario play out.

adamwill1113 wrote: I agree with everything you're saying, however, until an acquisition happens I think this stock will follow previous trends.

This means:

Run up to the conference calll -- 14-15 cents

If they meet guidance and continue current trend: stock slowly slides down during the ~5 month period of no news, reaching a low during the tax write-off period leading up to Christmas. Probably resting back around 11-12 cents.

If they miss guidance: stock tanks to 7-8 cents.

Unfortunately, until they deliver on their acquisition plan and build investor confidence by effectively managing expectations and sticking to timelines, this stock will always be undervalued.

Unfortunately, the lack of investor confidence makes sense. The team is consistently moving the goal posts with regard to acquisitions. Right now, investors are valuing the company as if an acquisition will never happen.